Clinical Liver Disease
SJR0.446
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.446 | Q3 | 56.9% | |
| 2024 | — | — | 0.680 | Q3 | 72.6% | |
| 2023 | — | — | 0.806 | Q2 | 80.0% | |
| 2022 | — | — | 0.545 | Q3 | 69.0% | |
| 2021 | — | — | 0.746 | Q3 | 79.2% | |
| 2020 | — | — | 0.421 | Q3 | 61.1% | |
| 2019 | — | — | 0.303 | Q4 | 52.7% | |
| 2018 | — | — | 0.372 | Q4 | 56.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2046-2484
country
UScoverage
2013-2024